AngioDynamics Inc
(FRA:UG2)
€
6.15
-0.1 (-1.67%)
Market Cap: 251.87 Mil
Enterprise Value: 205.71 Mil
PE Ratio: 0
PB Ratio: 1.41
GF Score: 66/100 AngioDynamics Inc at UBS Global Healthcare Virtual Conference Transcript
May 25, 2021 / 04:00PM GMT
Release Date Price:
€19.3
Matthew Charles Taylor
UBS Investment Bank, Research Division - Equity Research Analyst of Medical Supplies & Devices
Good afternoon, everybody, and joining us here for our next session in the MedTech track of the UBS Global Healthcare Conference, I'm pleased to be joined by management from AngioDynamics. We have joining us today, Jim Clemmer, who's President and CEO of the company. So Jim, it's a real pleasure to have you. Thanks a lot for joining us, and welcome to this session.
James C. Clemmer
AngioDynamics, Inc. - CEO, President & Director
Thanks, Matt, and thanks for UBS for inviting us. I look forward to taking the next session and talking to your investors about our company. So I look forward to it. Thank you, Matt.
Matthew Charles Taylor
UBS Investment Bank, Research Division - Equity Research Analyst of Medical Supplies & Devices
Great. So we're going to do kind of a split fireside chat here. We're going to have Jim run us through a few slides for the first half of the session, and then I'll
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot